CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret… - Seminars in cancer …, 2020 - Elsevier
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret… - Seminars in Cancer …, 2020 - hal.u-pec.fr
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret… - Seminars in Cancer …, 2020 - inria.hal.science
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret… - Seminars in Cancer …, 2020 - hal.science
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier… - … in Cancer Biology, 2020 - univ-rennes.hal.science
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier… - … in cancer biology, 2020 - pubmed.ncbi.nlm.nih.gov
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
[PDF][PDF] CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret, T Ducret… - researchgate.net
ABSTRACT CD95 (also known as Fas) is the prototype of death receptors; however,
evidence suggests that this receptor mainly implements non-apoptotic signaling pathways …
evidence suggests that this receptor mainly implements non-apoptotic signaling pathways …
[PDF][PDF] CD95/Fas and metastatic disease: What does not kill you makes you stronger
JP Guégan, C Ginestier, E Charafe-Jauffret, T Ducret… - academia.edu
CD95/Fas and metastatic disease: What does not kill you makes you stronger Page 1 HAL Id:
hal-02179928 https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179928 Submitted on 12 …
hal-02179928 https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179928 Submitted on 12 …
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
JP Guégan, C Ginestier, E Charafe-Jauffret… - Seminars in Cancer …, 2019 - europepmc.org
CD95 (also known as Fas) is the prototype of death receptors; however, evidence suggests
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …
that this receptor mainly implements non-apoptotic signaling pathways such as NF-κB …